A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Diclofenac Sodium Patch for the Topical Treatment of Pain Due to Mild to Moderate Ankle Sprain.
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 发起方
- 入组人数
- 170
- 试验地点
- 1
- 主要终点
- Assess the efficacy of diclofenac in subjects with mild to moderate ankle sprain.
研究概览
简要总结
The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium patch to the skin near or over the painful area. In this study, the location being studied will be either the left or right ankle.
The secondary purpose of this study is to assess the safety and tolerability of a diclofenac patch on the skin.
详细描述
Cerimon Pharmaceuticals is investigating a topical patch formulation of diclofenac sodium containing 15 mg of diclofenac sodium for the local treatment of acute musculoskeletal pain.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 to 75 years of age
- •Has sustained a painful Grade 1 or 2 ankle sprain (Appendix H) no more than 48 hours prior to study entry
- •Presence of pain of at least 5, with a maximum of 9, on an 11-point Numerical Rating Scale (NRS)
排除标准
- •Grade 3 ankle sprain or bilateral sprain (see Appendix H)
- •Previous injury to the same ankle within 3 months prior to current injury
- •Aspirin or short half-life NSAID use within 12 hours, or longer half-life NSAID use within 24 hours prior to study entry (Appendix B)
- •Opioid use within 24 hours prior to study entry
- •Topical treatment, other than ice packs, applied to the painful region since time of injury
- •A history of peptic ulcer disease within 1 year of study entry, any history of gastrointestinal bleeding or coagulation disorder
- •A history of, or evidence for, underlying disease in the injured ankle, such as osteoarthritis or gout
- •Clinically significant, poorly controlled pulmonary, gastrointestinal, hepatic, renal, endocrine, or cardiovascular disease
- •A history of hypersensitivity to diclofenac or diclofenac-containing products
- •A history of intolerance to acetaminophen (rescue medication in this trial)
- •A history of skin sensitivity to adhesives (e.g. adhesive tape)
- •Pregnant or breastfeeding women and women of child-bearing potential not using effective means of contraception
研究组 & 干预措施
A
Topical diclofenac sodium patch
干预措施: diclofenac sodium (Drug)
B
Topical patch identical in appearance to active comparator, except without diclofenac sodium
干预措施: Matching placebo patch (Drug)
结局指标
主要结局
Assess the efficacy of diclofenac in subjects with mild to moderate ankle sprain.
时间窗: 7 days
次要结局
- Assess the safety and tolerability of diclofenac in subjects with mild to moderate ankle sprain.(7 days)